Trial intelligence / Profile preview

MINOPTIC: Minocycline in the Treatment of Optic Neuritis

2011-001589-16Phase 2Completed

Sponsor
HUS Eye Hospital
Start
May 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in optic neuritis (ON) comparing Minocycline with Placebo (2 arms). Primary endpoint: Visual acuity at 6 months. Started May 2011; status: completed.

02

Drugs

minocycline
03

Conditions

optic neuritis (ON)

Beyond the preview

Go deeper on 2011-001589-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-001589-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call